Last update 01 Nov 2024
212Pb-DOTAM-GRPR1
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Radionuclide Drug Conjugates (RDC), Therapeutic radiopharmaceuticals |
Synonyms |
Target |
Mechanism GRPR antagonists(Gastrin releasing peptide receptor antagonists), Ionising radiation emitters |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Boost your research with our XDC technology data.
login
or
Related
1
Clinical Trials associated with 212Pb-DOTAM-GRPR1A Phase 1 Open-Label Dose Escalation and Expansion Study to Determine the Safety, Tolerability, Dosimetry, and Preliminary Efficacy of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
100 Clinical Results associated with 212Pb-DOTAM-GRPR1
Login to view more data
100 Translational Medicine associated with 212Pb-DOTAM-GRPR1
Login to view more data
100 Patents (Medical) associated with 212Pb-DOTAM-GRPR1
Login to view more data
100 Deals associated with 212Pb-DOTAM-GRPR1
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | Phase 1 | US | 22 Dec 2022 | |
| Colonic Cancer | Phase 1 | US | 22 Dec 2022 | |
| Melanoma, Cutaneous Malignant | Phase 1 | US | 22 Dec 2022 | |
| Metastatic Prostate Carcinoma | Phase 1 | US | 22 Dec 2022 | |
| Non-Small Cell Lung Cancer | Phase 1 | US | 22 Dec 2022 | |
| Uterine Cervical Cancer | Phase 1 | US | 22 Dec 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free